Table 9.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Liver Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		3,064	3,440	3,652	3,934	4,080	4,186	4,517	4,744	4,979	5,187
Tx With Follow-up Immunosuppression Info		2,308	2,634	2,860	3,131	3,174	3,354	3,662	3,798	4,087	4,278
Corticosteroids	Category Usage	93.0%	97.8%	98.2%	96.7%	95.2%	95.0%	92.8%	90.8%	90.4%	89.5%
	Steroids	93.0%	97.8%	98.2%	96.7%	95.2%	95.0%	92.8%	90.8%	90.4%	89.5%
Cyclosporine	Category Usage	79.2%	80.1%	66.1%	50.1%	42.4%	39.7%	33.6%	31.0%	23.7%	18.6%
	Cyclosporin	79.1%	79.9%	62.0%	25.7%	0.0%	0.0%	0.0%	0.1%	0.1%	0.0%
	Sandimmmune	1.5%	2.8%	6.0%	16.9%	8.9%	5.9%	7.3%	7.1%	5.6%	3.7%
	Neoral	0.1%	0.3%	3.1%	28.6%	37.3%	36.4%	29.4%	27.0%	20.4%	15.3%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	1.0%	1.9%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.2%	0.7%
Tacrolimus	Category Usage	23.8%	25.5%	43.6%	57.3%	64.2%	66.2%	73.3%	77.7%	83.8%	88.8%
	FK506	23.8%	25.5%	43.6%	57.3%	64.2%	66.2%	73.3%	77.7%	83.8%	88.8%
Antimetabolites	Category Usage	56.3%	57.9%	48.7%	43.6%	44.4%	43.6%	39.7%	49.3%	51.8%	53.2%
	Azathioprine	56.3%	57.4%	47.4%	33.5%	20.8%	17.7%	10.3%	8.3%	5.8%	4.5%
	Mycophenolate mofetil	0.0%	0.6%	1.7%	12.3%	24.9%	29.7%	31.5%	43.0%	47.5%	50.1%
Other	Category Usage	0.4%	0.5%	0.4%	0.4%	0.3%	0.4%	1.3%	3.3%	15.6%	16.9%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.2%	3.1%	15.2%	16.7%
	Cytoxan	0.4%	0.5%	0.4%	0.4%	0.3%	0.4%	0.1%	0.2%	0.4%	0.1%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.